Q32 Bio (NASDAQ:QTTB) Director Shelia Violette sold 2,815 shares of the company’s stock, valued at approximately $12,696, reducing her position by 4.82%. The stock’s performance shows a market cap of $56.1M with varying moving averages and a 52-week range of $1.35–$6.37. Analyst sentiment is mixed, with HC Wainwright initiating a “Buy” rating and a $13 price target, projecting profitability by FY2030, while consensus remains “Hold” due to significant projected near-term losses.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Insider Selling: Q32 Bio (NASDAQ:QTTB) Insider Sells 2,815 Shares of Stock
Q32 Bio (NASDAQ:QTTB) Director Shelia Violette sold 2,815 shares of the company’s stock, valued at approximately $12,696, reducing her position by 4.82%. The stock’s performance shows a market cap of $56.1M with varying moving averages and a 52-week range of $1.35–$6.37. Analyst sentiment is mixed, with HC Wainwright initiating a “Buy” rating and a $13 price target, projecting profitability by FY2030, while consensus remains “Hold” due to significant projected near-term losses.